Lead analytical development for biologics at Scholar Rock, overseeing method development, regulatory submissions, and team mentoring for monoclonal antibodies and complex biologics.
Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role.
Scholar Rock is the only company to show clinical proof of concept for a muscle-targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about the company’s approach at ScholarRock.com and follow @ScholarRock and on LinkedIn.
Summary of Position:
Scholar Rock is seeking an accomplished and strategic Senior Director of Analytical Development to lead analytical activities supporting the development and commercialization of innovative biologics, including monoclonal antibodies, fusion proteins, and bispecifics. This highly visible leadership role will oversee method development, characterization, analytical control strategies, and regulatory submissions spanning early-stage development through commercial lifecycle management. The ideal candidate will be a hands-on scientific leader with deep expertise in protein analytics and a strong track record of advancing programs from IND through BLA.
Position Responsibilities:
- Lead all aspects of analytical development across Scholar Rock's biologics portfolio, from early development through commercialization.
- End-to-end analytical ownership from preclinical through commercial, including lifecycle management of analytical methods.
- Oversight of both internal lab execution and external partnerships (CDMOs, CROs).
- Direct the design, development, qualification, and lifecycle management of analytical methods to support release, stability, comparability, and characterization testing.
- Define and implement phase-appropriate analytical control strategies integrated with QbD principles to support regulatory filings and commercial readiness.
- Establish and maintain product specifications in alignment with critical quality attributes (CQAs), clinical phase, manufacturing process understanding, and statistical justification.
- Collaborate with Process Development to ensure linkage between CQAs and process parameters.
- Oversee developability and manufacturability assessments for biologic drug candidates, integrating analytical data to evaluate protein stability, aggregation, degradation, solubility, charge variants, PTMs, and compatibility with formulation and drug delivery devices.
- Integrate analytical data into formulation selection and device interface development (e.g., high-concentration SubQ).
- Collaborate cross-functionally with Process Development, Formulation, Quality, Regulatory, and external CDMOs to ensure analytical alignment and technical robustness across all stages.
- Drive analytical comparability strategies to support process changes, site transfers, or lifecycle management.
- Define and execute regulatory strategies for analytical sections of CMC submissions (e.g., Module 3), support inspection readiness, and lead interactions with FDA, EMA, PMDA.
- Leverage data analytics platforms and advanced informatics tools to support method trending, OOS/OOT investigation, real-time release testing, and continued process verification.
- Serve as the analytical lead for Health Authority interactions, regulatory submissions (IND, IMPD, BLA/MAA), and inspections.
- Provide strategic leadership in CMC Teams, Analytical Sciences governance, and internal Scientific Review Boards.
- Mentor and grow a team of analytical scientists; foster a culture of scientific excellence, compliance, and technical leadership.
Candidate Requirements:
- Ph.D. in Analytical Chemistry, Biochemistry, or related discipline with 12+ years (or M.S. with 15+ years) of industry experience in analytical development for biologics.
- Proven experience leading analytical development for monoclonal antibodies or complex biologics through all stages of development, including BLA/MAA submission and commercial launch.
- Deep understanding of analytical methods (e.g., cIEF, SEC, CE-SDS, icIEF, LC-MS, peptide mapping, binding assays) and their application in CMC development and regulatory strategy.
- Demonstrated expertise in setting, justifying, and maintaining product specifications across the development lifecycle.
- Experience with developability profiling and integration of analytics into manufacturability risk assessment.
- Strong knowledge of ICH, USP, and regulatory expectations for biologics.
- Excellent leadership, strategic thinking, and communication skills.
Preferred Experience:
- Experience with high-concentration formulations and SubQ delivery.
- Prior leadership of external CDMO/CRO relationships.
Scholar Rock is an Equal Opportunity Employer. We celebrate diversity and are committed to creating an inclusive environment for all employees.
Top Skills
Binding Assays
Bioinformatics
Ce-Sds
Cief
Lc-Ms
Peptide Mapping
Sec
Scholar Rock Cambridge, Massachusetts, USA Office
301 Binney St, , Cambridge, Massachusetts , United States, 02142
Similar Jobs
Biotech
Lead analytical method development for small molecules and antisense oligonucleotides, ensuring compliance and innovation while managing a large scientific team.
Top Skills:
Analytical MethodsGmp ControlsRegulatory Requirements
Biotech
Lead the Analytical Development and Quality Control teams at nChroma Bio, focusing on gene therapy programs, method development, and regulatory compliance.
Top Skills:
Analytical MethodsBiophysical AnalyticsCell-Based AssaysGmp StandardsQuality Control Techniques
Fintech • Financial Services
The internship provides undergraduate students with practical experience in Commercial Banking, focusing on financial analysis, client needs assessment, and participation in structured activities for professional development.
Top Skills:
Microsoft Office (ExcelOutlookPowerpoint)Word
What you need to know about the Boston Tech Scene
Boston is a powerhouse for technology innovation thanks to world-class research universities like MIT and Harvard and a robust pipeline of venture capital investment. Host to the first telephone call and one of the first general-purpose computers ever put into use, Boston is now a hub for biotechnology, robotics and artificial intelligence — though it’s also home to several B2B software giants. So it’s no surprise that the city consistently ranks among the greatest startup ecosystems in the world.
Key Facts About Boston Tech
- Number of Tech Workers: 269,000; 9.4% of overall workforce (2024 CompTIA survey)
- Major Tech Employers: Thermo Fisher Scientific, Toast, Klaviyo, HubSpot, DraftKings
- Key Industries: Artificial intelligence, biotechnology, robotics, software, aerospace
- Funding Landscape: $15.7 billion in venture capital funding in 2024 (Pitchbook)
- Notable Investors: Summit Partners, Volition Capital, Bain Capital Ventures, MassVentures, Highland Capital Partners
- Research Centers and Universities: MIT, Harvard University, Boston College, Tufts University, Boston University, Northeastern University, Smithsonian Astrophysical Observatory, National Bureau of Economic Research, Broad Institute, Lowell Center for Space Science & Technology, National Emerging Infectious Diseases Laboratories
